A new paper by D J Bartram and D S Baldwin, published in this week's Veterinary Record, has found that veterinary surgeons are four times as likely as the general public, and around twice as likely as other healthcare professionals, to die by suicide as opposed to other causes.
Professor Bill Reilly, President of the British Veterinary Association, said: "David Bartram's research in this difficult area is to be applauded. The more we can understand about the reasons behind the high suicide rate amongst veterinary surgeons, the more the BVA and other bodies can do to support vets in crisis.
"As part of the Vetlife Steering Group, the BVA supports fantastic initiatives such as the 24-hour Vet Helpline for vets, vet nurses and veterinary students, and the Veterinary Benevolent Fund.
"The BVA's Member Services Group (MSG) also spends a lot of time looking at practical initiatives to improve individual vets' day-to day lives. The recent introduction of the mediation and representation services to help resolve issues between veterinary employees and veterinary employers is a good example of the positive ways in which the BVA can support its members in difficult situations.
"The MSG also recently produced a helpline sticker for all veterinary practices to display on the medicines cabinet and other prominent places to act as a constant reminder that help is available.
"Ours is a small profession and many vets will know a friend or colleague who has taken their own life. It is essential that this issue is kept in the open so that those who are struggling know where to turn for help."
Virbac has announced that it is hosting another day of CPD and surfing on Friday 26th April.
During the morning's session, Senior Field Veterinary Advisor Alex Allen BVM&S MRCVS will discuss 'Current thinking on companion animal vaccines', including CaniLeish, Virbac's vaccine for Leishmaniosis. Dermatologist Peri Lau-Gillard DrMedVet CertVD DipECVD MRCVS will then talk on 'Awful Atopics.'
The venue is the Atlantic Hotel, Newquay (close to Fistral Beach), with delegates transported to the nearby Surf School after lunch for their surfing lesson. A buffet lunch and post-surfing drinks will be provided by Virbac.
Territory manager and organiser Della Tomlinson said: "After last year's event we have had requests to repeat it from as far afield as London and Edinburgh, and we think that £30 for 3 hours of quality CPD is great value. As well as the obvious fun element of the surfing, we're deliberately holding the event on a Friday so vets can take advantage and enjoy a well-earned weekend away at a great location. Sadly this will have to be at your own expense!"
For more information or to book a place please contact Claire Lewis on 01359 243228 or claire.lewis@virbac.co.uk.
Bayer Animal Health, the maker of Veraflox, has produced a new animation which explains the considerations veterinary surgeons should take into account when choosing which antibiotic to prescribe.
The animation outlines the key steps that should be taken when faced with a suspected bacterial infection and includes factors such as culture and sensitivity testing, resistance and the mutant prevention concentration.
The company says it produced the animation in response to research it carried out last year in which nearly 500 veterinary professionals (465 practising vets and 45 students) participated.
48% said they felt that not enough is being done to educate veterinary professionals on the responsible use of antibiotics and how to avoid exacerbating the urgent issue of antimicrobial resistance.
Vicky McAlister, Group Product Manager at Bayer said: "In response to this research Bayer is developing a suite of educational resources to arm vets with practical and applicable tools that help them look beyond the 'tip of the iceberg' of bacterial infections, educating about not just the clinical cure, but bacteriological cure, too."
The animation is part of a wider awareness programme entitled ‘What Lies Beneath‘ in which Bayer says it aims to better understand the challenges the veterinary industry faces when prescribing antibiotics, so that additional tools can be developed to help vets confidently use antibiotics responsibly.
The programme will also include a series of webinars led by experts in various fields including veterinary medicine, laboratory diagnostics experts, behavioural psychologists and microbiologists. The webinars are due to be released later in the year, and will present a different perspective on common issues such as compliance, how to make appropriate antimicrobial choices and the approach to and interpretation of relevant diagnostic tests.
Zoetis has released new surveillance results which show that Mycoplasma bovis is becoming an increasingly significant pneumonia pathogen in cattle1.
In more than 2,500 samples submitted by vets for analysis during 2014, 45% were positive, compared with 41% in 2013.
According to Dr Tim Potter MRCVS from Westpoint Veterinary Group, Mycoplasma bovis has emerged as an important pathogen of calves worldwide2. He said: "It is associated with a number of clinical presentations including respiratory disease, otitis media and arthritis.
"The role of Mycoplasma bovis in pneumonia is well established and there are a number of reports in the literature of respiratory disease outbreaks where it was the predominant bacterium isolated. However, as with most causes of pneumonia, colonisation by Mycoplasma bovis alone is not always sufficient to cause disease and it may present in combination with other respiratory pathogens."
For other pathogens, the surveillance found 83% of samples positive for Para-influenza 3 virus (Pi3v), 76% Bovine Respiratory Syncytial virus (BRSv), 32% IBR, and 25% for BVD. Apart from BVD, which saw a three-point reduction from 28% the previous year - these show little change from 2013.
According to Zoetis vet Carolyn Hogan, in pneumonia outbreaks involving Mycoplasma bovis, many of the clinical signs are similar to those caused by other pneumonia pathogens: coughing, raised temperature, rapid breathing and lethargy.
She said: "This can make it difficult for farmers and vets alike to identify Mycoplasma bovis as a possible cause of disease based on clinical signs alone, unless calves are also showing some of the other distinguishing signs associated with Mycoplasma infection.
"These include ear infections, head shaking or tilting, and arthritis. Poor response to treatment, with resulting chronic respiratory cases, may also be suggestive of Mycoplasma infection. For a definitive diagnosis, of course, analysis of blood or respiratory tract mucous is required."
Whilst vaccination protection is available against the viruses (BRSv, Pi3v, BVD and IBR) and Mannheimia (Pasteurella) haemolytica, Carolyn points out that there is no ‘off the shelf’ vaccine available for Mycoplasma bovis. She adds that treatment can be challenging due to the insidious nature of disease, and lack of effectiveness of some antibiotics.
Once Mycoplasma bovis is present on a farm, Carolyn cautions that eradication can be very difficult. "It can be transmitted in milk from carrier cows, and in saliva among calves, particularly when multiple animals suckle the same teat feeders.
"Minimising this pathogen's impact on health and productivity relies on reducing its exposure to susceptible animals and maximising their resilience against it. For a comprehensive programme of control measures, farmers should consult their vet."
Carolyn suggests that such a programme is likely to include: testing the farm's Mycoplasma bovis status; effective biosecurity; not feeding infected milk; ample ventilation for adults and youngstock alike; rapid spotting of sick animals, isolation and vet-prescribed treatment; vigilance for poor response to treatment and development of chronic cases; vaccination against main viral pneumonia pathogens; and low stress through good stockmanship.
References
Photo: By Y tambe (Y tambe's file) [GFDL, CC-BY-SA-3.0 or CC BY-SA 2.5-2.0-1.0], via Wikimedia Commons
The collaborative study, which was sponsored by Norbrook, involved each practice blood testing a cohort of six lambs on 25 individual farms from 16 weeks of age, to look for evidence of antibodies to liver fluke.
Only 11 farms had positive results in the period from June, up to December, with most only showing one or two lambs out of the six sero-converting later in the year. Even farms located reasonably close by showed positive cases months apart.
Mark Thompson of Craven Farm Vets in Yorkshire said, “I did not expect to see positive results as late in the year. I expected a positive result earlier (September/October) as the farm is a very wet farm with a long-standing issue with fluke. Also, the weather in the area has been ideal for the intermediate host and fluke development on the pasture.”
Emily Baxter of Drove Farm Vets in Wiltshire said she thinks there is scope to use the results to improve the timing of dosing with flukicides and more responsible use: “We will use the results from this year’s testing to re-evaluate the farm’s fluke control protocol which will help reduce the level of use of flukicides earlier in the season for years with similar weather patterns and assist in planning of strategic grazing.
"We’re looking forward to continuing our work this year, no two years are ever the same, that’s why monitoring is so important. It will allow both ourselves and our clients to build up a picture over time of what’s happening not only on their individual farms, but potentially down to field level! This will allow us to provide more conclusive recommendations. For now, it’s clear that testing has great promise as a means to provide tailored advice to farms on how to control fluke and use the flukicides available to us responsibly.”
Emily says it’s important that farmers do not stop using flukicides based on the results of this study nor assume that there is less risk: “We all know how significant the losses from acute and chronic fascioliasis can be. We therefore encourage farmers to talk to their vet before they change their flukicide treatment protocols and discuss the possibility of using serology as an adjunct to determine how and when they treat.”
Veterinary professionals can find out more about the fluke sentinel project at https://xlvets-farm.co.uk/fluke-sentinel or the XLVets community at https://www.xlvets.co.uk/the-boss/.
Niall, who stepped up from Vice Chair to acting interim Chair of the Fellowship Board after the resignation of the previous Chair, has been formally elected as Chair of the Board.
In his role as Chair, Niall will continue to lead the Board, which is responsible for setting the criteria for joining the Fellowship across all three of its routes to entry, as well as the process by which applications are assessed.
An election for the position of Vice Chair of the Fellowship Board will take place in the autumn.
Niall said: “I am honoured beyond words to be elected Chair of the RCVS Fellowship and I'm very grateful for the support received to achieve this.
“I know I have very big shoes to fill, thanks to the great efforts that have gone on before and I will put all my available energy into continuing to work with our Fellows and the College to progress the goals of RCVS Fellowship as a resource of independent knowledge for our professions, to upskill and always innovate, while looking to enrich public awareness and discussion.”
Nicky Paull MRCVS, who has held the position of Chair of the Credentials Panel for the Meritorious Contributions to Clinical Practice pathway for the past three years, was successfully re-elected.
Nicky will continue to be responsible for making assessments of applicants aiming to gain Fellowship through the Meritorious Contributions to Clinical Practice pathway.
She will co-ordinate and oversee a review of the applications by her fellow panel members, as well as chairing any required appropriate panel meetings.
On her appointment, Nicky said: “I look forward to the challenge of continuing to grow the diversity of the Fellowship and celebrate those who, by their contribution to the advancement of the profession by clinical or educational scholarship and leadership, have had a significant impact on clinical practice within the veterinary profession.”
Niall and Nicky will be formally instated into their roles at Fellowship Day, which is due to take place on Thursday 28 November at One Great George Street, London.
https://www.rcvs.org.uk/fellowship/
The panel will present the latest information on the prevalence of this zoonotic disease, review prevention strategies, and highlight the significance of cystic echinococcosis in humans.
The panelists are:
Dr Carolyn Kyte MRCVS (pictured), Elanco's UK Technical Consultant said: “We are concerned about potential changes in the distribution of Echinococcus granulosus in the UK and a subsequent change in zoonotic risk.
"We are hoping this cross-disciplinary discussion will provide Congress and Expo attendees with the latest insights the profession needs to allow individual, risk-based parasite control in dogs.
"The responsible use of parasiticides needs a true One-Health collaborative approach.”
The 45-minute webinar: Debt Management: Prevention Is Better Than Cure is presented by Mike Brooks from veterinary-specialist debt recovery agency, dsl.
VPMA President Renay Rickard (pictured right) said: "Debt can affect any business, but, because of the role vets play as care-giver in an emotionally-based animal-owner relationship, we are particularly vulnerable. This is something that is commonly brought up by members at our regional meetings and events, and it’s a real dilemma for them how to juggle being strict with payment policies against owner expectations and misperceptions of the cost of veterinary medicine.
"This has been a very popular topic in both our regional meetings and with our webinar and we wanted to open it up to more people to help them tackle this topic in their practices. The feedback on this webinar has been very positive. Mike gives clear guidance on how to set up payment protocols that will minimise debt in such a way that maintains the client-practice relationship. There’s also information on how to recover existing debts. It makes sense to prioritise tackling this issue as if we’re not paid, then we can’t deliver the service that we are expected to, and that our patients need.
"We’re pleased to open this webinar up to all practices as a Christmas gift, and hope it will also highlight the support that is available through VPMA membership."
The webinar can be accessed through a link on the home page of the VPMA website www.vpma.co.uk.
The College says that although professional bodies advise their members to value their own wellbeing and seek help if unwell, there has been an absence of senior professionals who have felt able to say 'been there myself'.
By asking senior medical professionals to share their stories of overcoming struggles with mental health, &me aims to encourage other medical professionals to seek help, in part by showing that such experiences do not exclude people from achieving leading roles in healthcare.
With the addition of Dr Cathy Wield in August, there are now seven ambassadors for the &me campaign, and all of their stories can be read at www.vetmindmatters.org/&me:
Lizzie Lockett, Director of the Mind Matters Initiative, said: "Over the past eight months we have seen an incredible level of support for our &me ambassadors. Our Facebook post about Rob Pettitt, for example, reached nearly 25,000 people, many of whom posted stories about Rob helping them navigate veterinary school and better understand their own mental health issues. These kind of role models really do help reduce stigma, and we thank every one of our ambassadors for having the courage to share their own experiences with mental health."
Louise Freeman, Vice-Chair of the Doctors’ Support Network, said: "The &me campaign has really shown how the medical professions can work together when it comes to mental health. Medical professionals face many of the same challenges, and we needn’t face them alone – instead we can work as one to tackle stigma and speak openly about mental health issues. And it’s not just in the UK that health professionals can feel as if they are ‘not allowed’ to experience mental health problems. As a direct result of the &me campaign, health professionals from around the world including Australia and the U.S. have been in contact with DSN to confirm that they have similar issues within their local health culture."
The campaign is still interested in hearing from not only doctors and veterinary surgeons but also nurses, veterinary nurses, dentists, pharmacists and other healthcare professionals who want to open up about their experiences of mental ill health. To participate in the campaign, please email Dr Louise Freeman on vicechair@dsn.org.uk.
On social media tweets about the campaign are sent from @vetmindmatters and @DocSupportNet twitter accounts using the hashtag #AndMe.
Dechra Veterinary Products has announced the appointment of Bob Parmenter as managing director of its UK business.
Commenting on his appointment, Bob said: "I'm pleased to have joined Dechra at a very exciting stage of the company's development. I've been following the growth of Dechra over recent years and with its acquisition of VetXX in January, I believe that the business is now strongly placed to further establish itself as a leading player in the animal health industry."
Having spent nearly 40 years in the industry, Bob Parmenter has previously worked for Schering-Plough, Mallinckrodt Veterinary, Pitman-Moore, Coopers Animal Health and ICI Pharmaceuticals. "My career path has enabled me to experience all aspects of the animal health market. I'm confident my industry-wide knowledge will provide Dechra with additional experience as we continue to build our reputation and strengthen our UK market position."
Former MD Giles Coley, who joined Dechra in 1999 and has managed the UK business since 2003, has been promoted to European Pharmaceutical and Export Sales Director. As a member of Dechra Veterinary Product's European Board he will be responsible for co-ordinating pharmaceutical sales across Europe and developing the company's export sales.
US veterinary equipment manufacturer Midmark is holding a draw for a Matrx VMS anaesthesia machine, open to all UK veterinary practices.
Click this link, enter your details, and the winner will be announced on 7th July 2010.
The Animal Health Trust's (AHT) Dr Sue Dyson has been awarded a place in the International Equine Veterinarians Hall of Fame, in recognition of her contribution to hoof care in horses.
Sue, who is Head of Clinical Orthopaedics at the AHT, has lectured internationally and is known for both her clinical work with horses and an extensive research record, having published more than 200 refereed papers on lameness and diagnostic imaging in scientific journals. She has also co-authored several veterinary textbooks as well as training and competing as a high-level rider in international events.
Established in 1997, the International Equine Veterinarians Hall of Fame honours veterinary surgeons who have contributed to the knowledge and recognition of proper hoof care for horses. Vets are nominated either as practicing equine vets who work closely with farriers in the field, or as college and industry vets involved in teaching, research or other important aspects of equine veterinary and hoof care.
Anyone can nominate an equine vet for the award, which is sponsored by the American Farriers Journal, but selection is completed by previous inductees into the International Equine Veterinarians Hall of Fame. Awards are presented each year during the International Hoof-Care Summit in Cincinnati, Ohio.
Sue said: "I was completely surprised, but absolutely thrilled, to learn that I had been selected to join the distinguished list of people who have previously been appointed to the International Equine Veterinarians Hall of Fame.
"I think it is very humbling to recognise that, despite the knowledge that my team and I have amassed in the last 30 years, there is so much more to learn. From every new finding come many more questions. I hope that the enthusiastic dedication of my team will continue to result in learning and discovering more, and inspire others to do likewise, to the ultimate benefit of the welfare of our great friend, the horse."
Sue has has worked at the AHT for 30 years and is currently researching the association between hindlimb lameness and saddle slip. She has observed some association between the two for several years, however saddle slip has traditionally been attributed to an ill-fitting saddle, asymmetry of the horse's back shape or a crooked rider.
In 2011 Sue carried out a prospective research project with Intern Line Greve: 'Saddle slip may be an indicator of the presence of hindlimb lameness'. It was presented at the 51st Annual Congress of the British Equine Veterinary Association, Birmingham 2012, and identified that in some cases, saddle slip was directly linked to the presence of hindlimb lameness.
Research results showed that of 128 horses assessed for lameness grade and degree of saddle slip when ridden by two riders, the saddle consistently slipped to one side in 54% of the horses with hindlimb lameness, in comparison to just 4% of the horses with forelimb lameness. Diagnostic analgesia to abolish the hindlimb lameness eliminated the saddle slip in 97% of the horses observed in the study.
Sue and Line are currently undertaking further research to measure movement of the back, and forces under the saddle, with the aim of explaining biomechanically what is happening during the occurrence of saddle slip.
The training sessions are taking place both online and in person and places will be allocated on a first come first served basis.
Upcoming training dates are as follows:
https://www.vetmindmatters.org/training/
Following stock challenges earlier in the year, the company is now urging vets to encourage farmers to vaccinate their flocks to prevent abortions during lambing.
Roy Geary, regional director for Northern Europe at Ceva Animal Health, said: “While we realise that the temporary delay of Cevac Chlamydia has been inconvenient to our valued sheep farmers we would like to thank all our customers for their patience and support during this challenging time.
"The vaccine supply is now available in the UK for the latter end of the season.
"Farmers tupping later in October should therefore be encouraged to vaccinate their flocks to protect their ewes from this devastating disease.”
www.enzooticabortion.co.uk
Ian, who qualified from Melbourne University in 2004 after completing a neuroscience degree at Edinburgh University, first joined Rowe as a general practitioner in 2007.
He said: “Personally this achievement is incredibly rewarding, but I also see it as an important step for veterinary neurology in the UK.
"It’s a fast-growing field with an increasing need for expert treatment and care so it’s exciting to see it recognised at this level.”
https://www.rowereferrals.co.uk
Topics include applying the principles of antimicrobial stewardship (AMS), making confident diagnostic and prescribing decisions, and managing client expectations around antibiotic use within practice.
In the first episode, Tim explores how to apply the principles of AMS in the consulting room, starting with recognising when antibiotics are genuinely needed.
He explores the role of clinical signs and cytology in guiding diagnosis and treatment decisions, while also emphasising the risks of unnecessary prescribing.
The discussion also covers when empirical antibiotic use may be appropriate and how to ensure these decisions are justified.
Each episode offers practical, evidence-based insights which Krka says can be easily implemented in general practice.
The series is accompanied by downloadable Vet2Vet Insights information sheets that summarise the main take-home messages from each episode.
https://open.spotify.com/show/0uphORU03q29WncwmN2EIa
The information sheets are available here: https://www.krka.co.uk/veterinary-knowledge-hub/articles/responsible-use-of-companion-animal-antibiotics
Vets Now, the out-of-hours emergency services provider is to launch the Vets Now Hospital service in Glasgow city centre, where it will offer emergency and critical care together with a range of specialist referral options.
This follows on the heels of The University of Glasgow Small Animal Hospital, a new £15 million facility which opened at the end of August.
Vets Now says that the new hospitals and the range of clinical services on offer to the profession and pet owners will make the west of Scotland a centre of excellence in advanced clinical care for animals.
The opening of the two facilities will also offer both organisations a new platform on which to develop further their long standing relationship through future collaboration in the areas of teaching, training and investigation into animal disease.
Vets Now Group Managing Director, Richard Dixon said: "The opening of the two facilities presents a number of opportunities for both organisations to work collaboratively to develop teaching and training for undergraduates, residents, interns and nurses, and to work together to gain further understanding into animal disease through clinical investigation and the practice and promotion of evidence based medicine."
Professor Stuart Reid, Dean of the Faculty of Veterinary Medicine at the University said: "The expanded service which will be offered by the Small Animal Hospital and the new Vets Now Hospital obviously presents an enhanced range of choices for pet owners and first opinion vets in Scotland and an opportunity for both organisations to work collaboratively to ensure that undergraduates and clinical professionals have access to the best training and opportunities to develop professionally. We have enjoyed a mutually beneficial relationship for a number of years and we look forward to the new opportunities which the opening of the two hospitals will bring in the future."
The Small Animal Hospital opened on 31 August. The first Vets Now Hospital will open in Glasgow on 31 October.
Vygon Vet, a division of Vygon (UK) Ltd, has announced the launch of its website - www.vygonvet.co.uk.
Vygon has been supplying the veterinary market for 15 years. The new website means the company's products can now be bought direct online. The range includes: Vascular Access, IV Management, Needle-Free Devices, Respiratory, Digestive Tract, Regional Anaesthesia, Tissue Adhesive, Urinary & Rectal Tract and Theatre Products.
In addition to product information and technical data, the website offers guidance notes and tips about basic procedures.
Les Davies, Managing Director of Vygon (UK) Ltd said: "The launch of the new website demonstrates our commitment to the veterinary market and we hope that it not only enables veterinary professionals to order our products with ease, but that they also find the guidance notes and advice a valuable resource for their practice."
Vygon Vet products can also be ordered by telephone or through your veterinary wholesaler.
Novartis Animal Health UK has announced that it is committed to maintaining a reliable supply of Bovidec BVD virus vaccine throughout the coming season.
The announcement comes following concerns surrounding the availability of BVD vaccines. Novartis Brand Manager Eugene Smyth said: "We have been in discussion with the regulatory authorities to try and ensure we can meet the demand over the coming months and we have a large team of territory managers and technical services veterinarians dedicated to supporting our customers through the season".
Bovidec BVD virus vaccine, immunises adult cattle against the BVD Type 1 virus and for active immunisation of calves against BVD Type II virus.
The deadline for nominations for Practice of the Year, Vet of the Year, Vet Nurse of the Year, Practice Manager of the Year and Practice Support Staff of the Year, is 16th January.
The award ceremony will take place on 2nd April 2020 in Birmingham.
James Barnes, Head of Sales & Partnerships at Petplan, said: "We’ve been recognising the brilliant work of the UK’s veterinary professionals through the Petplan Veterinary Awards for 21 years now and every year the standard of entries just gets higher.
"The nominations are a testament to the hard work of all of those involved at practices who care for animals and clients all year round.
"The awards are a perfect opportunity for you to showcase your practice and your colleagues. Being acknowledged is great for team morale and a wonderful opportunity to raise the profile of the practice to new and existing clients alike. If you haven’t already I’d invite you to nominate someone today!"
You can nominate a colleague or your own practice at petplanvet.co.uk/vetawards, before nominations close on 16th January 2020.
BCF Technology has announced the launch of its new BUG ultrasound goggles. The company says that by using cutting-edge OLED display technology, BUGs deliver significant improvements in viewing images from fertility and pregnancy scanning of cattle, sheep, deer and goats.
BCF also says that BUGs are rugged and reliable, combining unprecedented display performance with excellent peripheral vision, and set a new standard in viewing ultrasound images. Optimised for grey scale imaging, the binocular style viewing features a full resolution display on which every ultrasound pixel is displayed. They are headband mounted for comfort and tough enough to suit any environment.
Gavin Mitchell, BCF’s Sales Director, said: “We spent over a year researching the needs of vets and developing the optimum technology for BUGs. We understand the problems that vets have experienced with monocular and binocular goggles, and we have successfully developed the ultimate solution for ultrasound scanning.”
Andrew Bronson, Cattle Vet, Alberta, Canada, said; "These durable goggles give me great peripheral vision when scanning cattle, which means that scanning is a lot safer. With the larger field of view and improved image quality over monocular goggles, I’ve finally found a permanent solution for portable ultrasound."
Charles Marwood, BVM & S, MRCVS, Clyde Veterinary Group, Scotland, said: "These goggles give a crisp, superior image and a fantastic resolution. They are very comfortable to wear with no safety issues."
BUGs are designed specifically for use with the BCF Easi-Scan ultrasound scanner. For more information, visit: http://www.bcftechnology.com/
The RCVS Council has announced its agreement with wholesale reform of the College’s governance arrangements to improve the efficiency and accountability of its decision-making processes.
The changes agreed by Council included almost halving the number of Council members and formalising lay and veterinary membership.
Under the proposals approved by Council it would be reduced to 24 members – comprising 13 elected veterinary surgeons (constituting a majority of Council), six appointed laypeople, three members appointed on behalf of the UK veterinary schools and two veterinary nurses. There would also be the option to appoint an additional member on behalf of any allied professions that RCVS Council may choose to regulate as associates of the College.
Professor Stuart Reid, Senior Vice-President of the RCVS and Chair of the Governance Panel that developed the recommendations, said: "I am delighted that Council so fully supported our proposals for a new structure. The new composition will ensure that both veterinary nurses and laypeople have a guaranteed place at the Council table, as well as maintaining a majority of elected veterinary surgeons and important input from the veterinary schools.
"The proposal recognises the unique nature of the RCVS and will allow us to expedite our decision-making process, making us more fleet of foot and better able to respond to the needs of the profession and the public. It has also been constructed to allow Council to evolve its position, ensuring it remains relevant into the future. If all goes well we hope that the changes could come into force as soon as March 2017."
Liz Cox, the Chair of VN Council, particularly welcomed the changes in respect of veterinary nursing representation on RCVS Council, adding: "It is an historic decision for veterinary nurses and one that has been long awaited. It is only right that those who work so closely alongside veterinary surgeons in practice should have a direct input into regulation that affects us all."
Council’s approval of the recommendations was the culmination of two years of debate and consultation with the profession and other stakeholders. This included a formal consultation by the Department for Environment, Food and Rural Affairs (Defra) last year which garnered 52 responses – including from the British Veterinary Association - most of which were supportive. Different options for reform had, in turn, been developed by a Governance Panel, chaired by Professor Reid, which was set up by Council in March 2015 to consider various options.
Defra will now run a short informal consultation to provide those who responded to the initial consultation the opportunity to comment on the proposed reforms. If no issues are raised Defra officials will seek approval from the Government to proceed with a legislative reform order (LRO) to make the necessary changes to the Veterinary Surgeons Act.
This LRO will be scrutinised by parliamentary committee and voted on in both the House of Commons and House of Lords. Once this has been passed there will be a three-year transitional period, agreed by Council members, during which Council’s numbers would be gradually reduced.
Genitrix has launched a new system called Osteokine, which produces Platelet-Rich-Plasma (PRP). PRP, an autologous solution containing therapeutically significant concentrations of platelets, is known to accelerate the healing of injuries and is already widely used in human medicine. It is increasingly being used in the treatment of horses.
The Osteokine system, developed by German company Orthogen which also manufactures joint therapy Irap, comprises two interconnected blood bags.
The system involves taking citrated whole blood from the horse and placing it into the first, red-capped Osteokine bag for processing in a centrifuge. The plasma and platelets are then transferred to the second bag, and a second centrifuge process separates the plasma and generates a pellet of PRP, which is extracted and used to treat the horse from which it was taken.
Treatment with PRP has been shown to accelerate wound healing in all kinds of tissue particularly tendons and ligaments and has also been used in bone healing. It has been noted to reduce perioperative traumatic pain while the higher collagen content provided by PRP can create improved scar resistance.
Commenting on the launch of the Osteokine system in the UK, Rob Watkins, Marketing Director of Genitrix, said: "Therapeutic care of equine lameness is an area of particular expertise for Genitrix and the innovative treatments we've brought to market, including Acell, HY50 and Irap already form part of the staple ‘toolkit' of many equine vets.
"The benefits of PRP in terms of accelerating wound healing and vasculerisation are already widely accepted as are the advantages of an autologous approach in terms of eliminating the risk of disease transmission. To date, however, the process of extracting PRP has proved complex and expensive and only provided in specialised laboratories.
"Osteokine, in contrast, offers a cost-effective approach based on a system which is simple to operate in practice and takes only 20 minutes. We believe it offers a highly effective approach to treating wounds and injuries in horses."
For further information on Osteokine, contact Genitrix on 01403 786345.